The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
Open accessAbstract
Ependymomas are common childhood brain tumours that occur throughout the nervous system, but are most common in the paediatric hindbrain. Current standard therapy comprises surgery and radiation, but not cytotoxic chemotherapy as it does not further increase survival. Whole-genome and whole-exome sequencing of 47 hindbrain ependymomas reveals an extremely low mutation rate, and zero significant recurrent somatic single nucleotide variants. Although devoid of recurrent single nucleotide variants and focal copy number aberrations, poor-prognosis hindbrain ependymomas exhibit a CpG island methylator phenotype. Transcriptional silencing driven by CpG methylation converges exclusively on targets of the Polycomb repressive complex 2 which represses expression of differentiation genes through trimethylation of H3K27. CpG island methylator phenotype-positive hindbrain ependymomas are responsive to clinical drugs that target either DNA or H3K27 methylation both in vitro and in vivo. We conclude that epigenetic modifiers are the first rational therapeutic candidates for this deadly malignancy, which is epigenetically deregulated but genetically bland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“many of the enzymes targeted, particularly lysine and arginine methyltransferases, have non-histone substrates”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [183]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Román‐Gómez, J., Jiménez‐Velasco, A., Agirre, X., Prósper, F., Heiniger, A., & Torres, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4944 · Cited by 128
RetractedComprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationThe Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Self-citationComprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Self-citationDriver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Self-citationA landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Cited by
Sorted by citations
Items 201–300 of 608
Wang, Z. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.002 · Cited by 36
Reuniting philosophy and science to advance cancer research
Pradeu, T., Daignan‐Fornier, B., Ewald, A. J., Germain, P., Okasha, S., Plutynski, A., Benzekry, S., Bertolaso, M., Bissell, M. J., Brown, J. S., et al. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12971 · Cited by 37
Stem cell cultures derived from pediatric brain tumors accurately model the originating tumors
Wenger, A., Larsson, S. C., Danielsson, A., Elbæk, K. J., Kettunen, P., Tisell, M., Sabel, M., Lannering, B., Nordborg, C., Schepke, E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14826 · Cited by 37
Nambirajan, A., Sharma, A., Rajeshwari, M., Boorgula, M. T., Doddamani, R. S., Garg, A. K., Suri, V. S., Sarkar, C., & Sharma, M. C. (2020) · Brain Tumor Pathology · doi:10.1007/s10014-020-00385-9 · Cited by 35
van Neerven, S. M., Tieken, M., Vermeulen, L., & Bijlsma, M. F. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1098791 · Cited by 37
Adult Primary Brain Neoplasm, Including 2016 World Health Organization Classification
Wang, K. Y., Chen, M., & Lincoln, C. M. M. (2019) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2019.07.004 · Cited by 36
Posterior fossa ependymoma: current insights
Thompson, Y. Y., Ramaswamy, V., Diamandis, P., Daniels, C. E., & Taylor, M. D. (2015) · Child s Nervous System · doi:10.1007/s00381-015-2823-2 · Cited by 34
Self-citationGenetics of Common Pediatric Brain Tumors
Malbari, F., & Lindsay, H. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.08.004 · Cited by 36
Li, A. M., Dunham, C. P., Tabori, U. Y., Carret, A., McNeely, P. D., Johnston, D. L., Lafay‐Cousin, L., Wilson, B. A., Eisenstat, D. D., Jabado, N., et al. (2015) · Cancer · doi:10.1002/cncr.29198 · Cited by 33
Self-citationTranslating genomic discoveries to the clinic in pediatric oncology
Bender, J. G., Verma, A. R., & Schiffman, J. D. (2014) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000172 · Cited by 33
Landskron, L., Steinmann, V., Bonnay, F., Burkard, T. R., Steinmann, J., Reichardt, I., Harzer, H., Laurenson, A.-S., Reichert, H., & Knoblich, J. A. (2018) · eLife · doi:10.7554/elife.31347 · Cited by 33
Malbari, F. (2021) · Neurologic Clinics · doi:10.1016/j.ncl.2021.04.005 · Cited by 37
Defining the Molecular Landscape of Ependymomas
Archer, T. C., & Pomeroy, S. L. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.015 · Cited by 32
Self-citationC11orf95–RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma
Cachia, D., Wani, K., Peñas-Prado, M., Olar, A., McCutcheon, I. E., Benjamin, R. S., Armstrong, T. S., Gilbert, M. R., & Aldape, K. (2014) · Brain Tumor Pathology · doi:10.1007/s10014-014-0205-1 · Cited by 33
Self-citationMack, S. C., & Northcott, P. A. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.9921 · Cited by 32
Self-citationIntracranial ependymomas: molecular insights and translation to treatment
Lester, A., & McDonald, K. L. (2019) · Brain Pathology · doi:10.1111/bpa.12781 · Cited by 32
Huston, A., Arrowsmith, C. H., Knapp, S., & Schapira, M. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1871 · Cited by 33
Smith, E. N., Ghia, E. M., DeBoever, C., Rassenti, L. Z., Jepsen, K., Yoon, K.-A., Matsui, H., Rozenzhak, S., Alakus, H., Shepard, P. J., et al. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.14 · Cited by 33
A Nonquiescent “Idling” Population State in Drug-Treated, BRAF-Mutated Melanoma
Paudel, B. B., Harris, L. A., Hardeman, K. N., Abugable, A. A., Hayford, C. E., Tyson, D. R., & Quaranta, V. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.01.016 · Cited by 31
Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
Pun, M. J., Pratt, D. W., Nano, P. R., Joshi, P. K., Jiang, L., Englinger, B., Rao, A. U. K., Cieslik, M. P., Chinnaiyan, A. M., Aldape, K., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01514-z · Cited by 31
Self-citationRecent Advances in the Classification and Treatment of Ependymomas
Leeper, H. E., Felicella, M. M., & Walbert, T. (2017) · Current Treatment Options in Oncology · doi:10.1007/s11864-017-0496-7 · Cited by 31
Epigenetic Deregulation in Human Primary Immunodeficiencies
Campos‐Sánchez, E., Martínez-Cano, J., Molina, L. D. P., López‐Granados, E., & Cobaleda, C. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.11.005 · Cited by 31
An epigenetic therapy for diffuse intrinsic pontine gliomas
Ramaswamy, V., Remke, M., & Taylor, M. D. (2014) · Nature Medicine · doi:10.1038/nm.3769 · Cited by 30
Self-citationTreatment implications of posterior fossa ependymoma subgroups
Ramaswamy, V., & Taylor, M. D. (2016) · 癌症：英文版 · doi:10.1186/s40880-016-0155-6 · Cited by 30
Self-citationGenetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors
Testa, U., Castelli, G., & Pelosi, E. (2018) · Medical Sciences · doi:10.3390/medsci6040085 · Cited by 33
SMT and TOFT: Why and How They are Opposite and Incompatible Paradigms
Bizzarri, M., & Cucina, A. (2016) · Acta Biotheoretica · doi:10.1007/s10441-016-9281-4 · Cited by 31
Further understanding of the pathology of glioma: implications for the clinic
Camelo-Piragua, S. I., & Kesari, S. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1194755 · Cited by 29
Zakrzewska, M., Fendler, W. M., Zakrzewski, K. M., Sikorska, B., Grajkowska, W., Dembowska-Baginska, B. M., Filipek, I., Stefanczyk, L., & Liberski, P. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158464 · Cited by 29
Self-citationNam, S. J., Kim, Y., Park, J. E., Ra, Y., Khang, S. K., Cho, Y. H., Kim, J. H., & Sung, C. O. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2278-x · Cited by 29
Self-citationEpigenomics-Guided Drug Development: Recent Advances in Solving the Cancer Treatment “jigsaw puzzle”
Dzobo, K. (2019) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0206 · Cited by 29
Distinct circular RNA expression profiles in pediatric ependymomas
Ahmadov, U., Bendikas, M. M., Ebbesen, K. K., Sehested, A. M., Kjems, J., Broholm, H., & Kristensen, L. S. (2020) · Brain Pathology · doi:10.1111/bpa.12922 · Cited by 30
Polycomb repressive complex 2 in the driver’s seat of childhood and young adult brain tumours
Krug, B., Harutyunyan, A. S., Deshmukh, S., & Jabado, N. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.05.006 · Cited by 29
Self-citationSavage, P. M., Monk, D., Mora, J. R. H., van der Westhuizen, N., Rauw, J. M., Tinker, A. V., Robinson, W. P., Song, Q., Seckl, M. J., & Fisher, R. A. (2019) · BMC Cancer · doi:10.1186/s12885-019-5906-8 · Cited by 29
Donson, A. M., Bertrand, K. C., Riemondy, K. A., Gao, D., Zhuang, Y., Sanford, B. L., Norris, G. A., Chapman, R. J., Fu, R., Willard, N., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad096 · Cited by 28
Self-citationEpigenetic regulation leading to induced pluripotency drives cancer development in vivo
Ohnishi, K., Semi, K., & Yamada, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.020 · Cited by 27
Sandberg, D. I., Yu, B., Patel, R., Hagan, J. P., Miesner, E., Sabin, J., Smith, S., Fletcher, S. A., Shah, M. N., Sirianni, R. W., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03055-1 · Cited by 28
Self-citationOkonechnikov, K., Camgöz, A., Chapman, O. S., Wani, S., Park, D., Hübner, J.-M., Chakraborty, A., Pagadala, M., Bump, R., Chandran, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38044-0 · Cited by 27
Self-citationPediatric Cancer Epigenome and the Influence of Folate
Yiu, T. T., & Li, W. (2015) · Epigenomics · doi:10.2217/epi.15.42 · Cited by 27
Put away your microscopes: the ependymoma molecular era has begun
Mack, S. C., & Taylor, M. D. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000411 · Cited by 27
Self-citationEpigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges
Pei, W., Zhang, Y., Yin, T., & Yu, Y. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz035 · Cited by 28
Origin of Cancer: Cell work is the Key to Understanding Cancer Initiation and Progression
Hanselmann, R. G., & Welter, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.787995 · Cited by 31
Aubin, R. G., Troisi, E. C., Montelongo, J., Alghalith, A. N., Nasrallah, M. P., Santi, M., & Cámara, P. G. (2022) · Nature Communications · doi:10.1038/s41467-022-31683-9 · Cited by 30
Wang, J., Han, X., & Sun, Y. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-0253-7 · Cited by 27
Servidei, T., Meco, D., Muto, V., Bruselles, A., Ciolfi, A., Trivieri, N., Lucchini, M., Roberta Morosetti, A., Massimiliano Mirabella, A., Martini, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0790 · Cited by 27
Jünger, S. T., Mynarek, M., Wohlers, I., Dörner, E., Mühlen, A. Z., Char, N. V., von Hoff, K., Rutkowski, S., Warmuth‐Metz, M., Kortmann, R., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0820-5 · Cited by 27
Genome-Wide Epigenetic Studies in Human Disease: A Primer on -Omic Technologies
Yan, H., Tian, S., Slager, S. L., Sun, Z., & Ördög, T. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv187 · Cited by 26
Molecular dissection of ependymomas
Pajtler, K. W., Pfister, S. M., & Kool, M. (2015) · Oncoscience · doi:10.18632/oncoscience.202 · Cited by 26
Self-citationPaediatric Strategy Forum for medicinal product development of epigenetic modifiers for children
Pearson, A. D. J., Stegmaier, K., Bourdeaut, F., Reaman, G. H., Heenen, D. L., Meyers, M. L., Armstrong, S. A., Brown, P. A., Carvalho, D. D. D., Jabado, N., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.08.014 · Cited by 26
Self-citationNew Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy
Fuller, C. E., Jones, D., & Kieran, M. W. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175088 · Cited by 26
Self-citationIntratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis
Bilen, M. A., Hess, K. R., Campbell, M. T., Wang, J., Broaddus, R. R., Karam, J. A., Ward, J. F., Wood, C. G., Choi, S. L., Rao, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13380 · Cited by 28
Veo, B. L., Danis, E. P., Pierce, A. M., Sola, I., Wang, D., Foreman, N. K., Jin, J. J., Ma, A., Serkova, N. J., Venkataraman, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.122933 · Cited by 26
Sox9 directs divergent epigenomic states in brain tumor subtypes
Sardar, D., Chen, H., Reyes, A., Varadharajan, S., Jain, A., Mohila, C., Curry, R. N., Lozzi, B., Rajendran, K., Cervantes, A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202015119 · Cited by 24
Self-citationMolecular genetics of ependymomas and pediatric diffuse gliomas: a short review
Nobusawa, S., Hirato, J., & Yokoo, H. (2014) · Brain Tumor Pathology · doi:10.1007/s10014-014-0200-6 · Cited by 25
Dorfer, C., Tonn, J. C., & Rutka, J. T. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802997-8.00025-6 · Cited by 25
Self-citationBrücher, B. L. D. M., Li, Y., Schnabel, P. A., Däumer, M., Wallace, T. J., Kube, R., Zilberstein, B., Steele, S. R., Voskuil, J. L. A., & Jamall, I. S. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0093-6 · Cited by 25
Zhou, J., Cisneros, L. H., Knijnenburg, T., Trachana, K., Davies, P. C. W., & Huang, S. (2018) · Convergent Science Physical Oncology · doi:10.1088/2057-1739/aab1b0 · Cited by 27
Challenges and Opportunities for Childhood Cancer Drug Development
Houghton, P. J., & Kurmasheva, R. T. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.016972 · Cited by 25
Cancer stem cells modulate patterns and processes of evolution in cancers
Laplane, L. (2018) · Biology & Philosophy · doi:10.1007/s10539-018-9629-z · Cited by 26
Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies
Tran, T. H., Shah, A. T., & Loh, M. L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0115 · Cited by 24
Tumoral reprogramming: Plasticity takes a walk on the wild side
Campos‐Sánchez, E., & Cobaleda, C. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.07.003 · Cited by 24
Treatment and survival of supratentorial and posterior fossa ependymomas in adults
Nuño, M., Yu, J. J., Varshneya, K., Alexander, J. E., Mukherjee, D. R., Black, K. L., & Patil, C. G. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.11.014 · Cited by 24
Yan, H., Tian, S., Slager, S. L., & Sun, Z. (2016) · Epigenomics · doi:10.2217/epi-2016-0053 · Cited by 25
Trimarchi, M. P., Yan, P. S., Groden, J. L., Bundschuh, R. A., & Goodfellow, P. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173242 · Cited by 24
Precision Medicine in Pediatric Neurooncology: A Review
Mochizuki, A. Y., Frost, I. M., Mastrodimos, M. B., Plant, A., Wang, A., Moore, T. B., Prins, R. M., Weiss, P. S., & Jonas, S. J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00388 · Cited by 26
Minireview: The Epigenetic Modulation of KISS1 in Reproduction and Cancer
Motti, M. L., & Meccariello, R. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16142607 · Cited by 24
Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome
Jünger, S. T., Andreiuolo, F. D. M., Mynarek, M., Dörner, E., Mühlen, A. Z., Rutkowski, S., von Bueren, A. O., & Pietsch, T. (2020) · Child s Nervous System · doi:10.1007/s00381-020-04655-x · Cited by 24
The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma
Jung, M., Kim, S., Lim, K. Y., Bae, J., Park, C., Choi, S. H., Park, S., & Won, J. (2021) · Human Pathology · doi:10.1016/j.humpath.2021.06.005 · Cited by 24
TULIPs decorate the three-dimensional genome of PFA ependymoma
Johnston, M. J. G., Lee, J. J. Y., Hu, B., Nikolić, A., Hasheminasabgorji, E., Baguette, A., Paik, S., Chen, H., Kumar, S. A., Chen, C. C. L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.023 · Cited by 22
Self-citationAdvances in Management of Pediatric Ependymomas
Lin, F. Y. H., & Chintagumpala, M. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0470-0 · Cited by 23
DNA methylation in cancer: three decades of discovery
Feinberg, A. P. (2014) · Genome Medicine · doi:10.1186/gm553 · Cited by 22
Brain Tumors: Challenges and Opportunities to Cure
Mellinghoff, I. K., & Gilbertson, R. J. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.2965 · Cited by 22
Torres‐Martín, M., Lassaletta, L., de Campos, J. M., Isla, A., Pinto, G. R., Burbano, R. M. R., Meléndez, B., Castresana, J. S., & REY, J. A. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22232 · Cited by 23
Lehtinen, B., Raita, A., Kesseli, J., Annala, M., Nordfors, K., Yli-Harja, O. P., Zhang, W., Visakorpi, T., Nykter, M., Haapasalo, H. K., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3274-9 · Cited by 22
Griesinger, A. M., Witt, D. A., Grob, S. T., Westover, S. R. G., Donson, A. M., Sanford, B. L., Levy, J. M. M., Wong, R., Moreira, D. C., DeSisto, J. A., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox061 · Cited by 22
The Stem Cell Division Theory of CancerPreprint
López‐Lázaro, M. (2017) · Preprints.org · doi:10.20944/preprints201707.0074.v1 · Cited by 21
Azizgolshani, N., Petersen, C. L., Chen, Y., Levy, J., Salas, L. A., Perreard, L., Nguyen, L., & Christensen, B. C. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01156-9 · Cited by 23
Molecular subtyping of ependymoma and prognostic impact of Ki-67
Lim, K. Y., Lee, K.-H., Shim, Y., Park, J. W., Kim, H., Kang, J., Won, J., Kim, S., Phi, J. H., Park, C., et al. (2021) · Brain Tumor Pathology · doi:10.1007/s10014-021-00417-y · Cited by 21
The therapeutic potential of targeting the PI3K pathway in pediatric brain tumors
Rogers, H. A., Estranero, J. G., Gudka, K., & Grundy, R. G. (2016) · Oncotarget · doi:10.18632/oncotarget.13781 · Cited by 21
Cancer-associated chromatin variants uncover the oncogenic role of transposable elements
Grillo, G., & Lupien, M. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101911 · Cited by 21
Self-citationGenomic characterization of recurrent high-grade astroblastoma
Bale, T. A., Abedalthagafi, M., Bi, W. L., Kang, Y. J., Merrill, P. H., Dunn, I. F., Dubuc, A. M., Charbonneau, S. K., Brown, L. E., Ligon, A. H., et al. (2016) · Cancer Genetics · doi:10.1016/j.cancergen.2016.06.002 · Cited by 20
Self-citationJeyapalan, J. N., Doctor, G. T., Jones, T. A., Alberman, S., Tep, A., Haria, C. M., Schwalbe, E. C., Morley, I., Hill, A., LeCain, M., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0323-6 · Cited by 23
Epigenetic Priming in Immunodeficiencies
Martínez-Cano, J., Campos‐Sánchez, E., & Cobaleda, C. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00125 · Cited by 21
Partap, S., & Monje, M. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000955 · Cited by 21
de Sousa, G. R., Lira, R. C. P., Magalhães, T. D. A., da Silva, K. R., Nagano, L. F. P., Saggioro, F. P., Baroni, M., Marie, S. K. N., Oba‐Shinjo, S. M., Brandelise, S., et al. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02074-2 · Cited by 20
Author-sourced capture of pathway knowledge in computable form using Biofactoid
Wong, J. V., Franz, M., Siper, M. C., Fong, D., Durupınar, F., Dallago, C., Luna, A., Giorgi, J., Rodchenkov, I., Babur, Ö., et al. (2021) · eLife · doi:10.7554/elife.68292 · Cited by 20
Self-citationEpigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas
Zhao, S., Li, J., Zhang, H., Qi, L., Du, Y., Kogiso, M., Braun, F., Xiao, S., Huang, Y., Li, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34514-z · Cited by 19
Wagner, M. W., Maralani, P. J., Bennett, J., Nobre, L. F., Lim-Fat, M. J., Dirks, P. B., Laughlin, S., Tabori, U. Y., Ramaswamy, V., Hawkins, C. E., et al. (2024) · Radiology · doi:10.1148/radiol.230777 · Cited by 19
Self-citationIntegrating RNA sequencing into neuro-oncology practice
Rogawski, D. S., Vitanza, N. A., Gauthier, A. C., Ramaswamy, V., & Koschmann, C. J. (2017) · Translational research · doi:10.1016/j.trsl.2017.06.013 · Cited by 20
Self-citationBiomarkers in tumors of the central nervous system – a review
Scheie, D., Kufaishi, H., Broholm, H., Lund, E. L., de Stricker, K., Melchior, L. C., & Grauslund, M. (2019) · Apmis · doi:10.1111/apm.12916 · Cited by 21
Servidei, T., Meco, D., Martini, M., Battaglia, A., Granitto, A., Buzzonetti, A., Babini, G., Massimi, L., Tamburrini, G., Scambia, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041877 · Cited by 19
Self-citationThe Emerging Molecular Foundations of Pediatric Brain Tumors
Huse, J. T., & Rosenblum, M. K. (2015) · Journal of Child Neurology · doi:10.1177/0883073815579709 · Cited by 19
Reprogramming cancer cells to pluripotency
Stricker, S. H., & Pollard, S. M. (2014) · Epigenetics · doi:10.4161/epi.28600 · Cited by 18
DREAM: A Simple Method for DNA Methylation Profiling by High-throughput Sequencing
Jelı́nek, J., & Madžo, J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-4011-0_10 · Cited by 18
Hwang, E. I., Hanson, D. J., Filbin, M. G., & Mack, S. C. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100895 · Cited by 18
Self-citationCase-based review: ependymomas in adults
Cachia, D., Johnson, D. R., Kaufmann, T. J., Lowe, S. R., Andersen, S., Olar, A., Cooper, S. L., Frankel, B. M., & Gilbert, M. R. (2018) · Neuro-Oncology Practice · doi:10.1093/nop/npy026 · Cited by 18
Primary Neoplasms of the Pediatric Brain
Jaimes, C. E., & Poussaint, T. Y. (2019) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2019.06.004 · Cited by 18
Molecular tumor classification using DNA methylome analysis
Sill, M., Plass, C., Pfister, S. M., & Lipka, D. B. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa147 · Cited by 18
Self-citationClinical Genomics: Challenges and Opportunities
Vijay, P., McIntyre, A. B. R., Mason, C. E., Greenfield, J. P., & Li, S. (2016) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2016015724 · Cited by 18
Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics
Li, Y., Li, Z., & Zhu, W. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170921101947 · Cited by 20
Effects of Culture Condition on Epigenomic Profiles of Brain Tumor Cells
Cox, M. C., Deng, C., Naler, L. B., Lu, C., & Verbridge, S. S. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00161 · Cited by 18
Metadata
- Authors
- Mack, S. C., Witt, H., Piro, R. M., Gu, L., Zuyderduyn, S., Stütz, A. M., Wang, X., Gallo, M., Garzia, L., Zayne, K., Zhang, X., Ramaswamy, V., Jäger, N., Jones, D. T. W., Sill, M., Pugh, T. J., Ryzhova, M., Wani, K. M., Shih, D. J. H., Head, R., Remke, M., Bailey, S. D., Zichner, T., Faria, C. C., Barszczyk, M., Stark, S., Seker-Cin, H., Hutter, S., Johann, P., Bender, S., Hovestadt, V., Tzaridis, T., Dubuc, A. M., Northcott, P. A., Peacock, J., Bertrand, K. C., Agnihotri, S., Cavalli, F. M. G., Clarke, I., Nethery-Brokx, K., Creasy, C. L., Verma, S. K., Koster, J., Wu, X., Yao, Y., Milde, T., Sin-Chan, P., Zuccaro, J., Lau, L., Pereira, S., Castelo-Branco, P., Hirst, M., Marra, M. A., Roberts, S. S., Fults, D., Massimi, L., Cho, Y. J., Van Meter, T., Grajkowska, W., Lach, B., Kulozik, A. E., von Deimling, A., Witt, O., Scherer, S. W., Fan, X., Muraszko, K. M., Kool, M., Pomeroy, S. L., Gupta, N., Phillips, J., Huang, A., Tabori, U., Hawkins, C., Malkin, D., Kongkham, P. N., Weiss, W. A., Jabado, N., Rutka, J. T., Bouffet, E., Korbel, J. O., Lupien, M., Aldape, K. D., Bader, G. D., Eils, R., Lichter, P., Dirks, P. B., Pfister, S. M., Korshunov, A., & Taylor, M. D.
- Affiliations
- University of Toronto (CA)
- German Cancer Research Center (DE)
- European Molecular Biology Laboratory (DE)
- Hospital for Sick Children (CA)
- Dartmouth–Hitchcock Medical Center (US)
- Boston Children's Hospital (US)
- The University of Texas MD Anderson Cancer Center (US)
- Ontario Institute for Cancer Research (CA)
- GlaxoSmithKline (United States) (US)
- BC Cancer Agency (CA)
- Uniformed Services University of the Health Sciences (US)
- University of Utah (US)
- Agostino Gemelli University Polyclinic (IT)
- Stanford Medicine (US)
- Children's Memorial Health Institute (PL)
- Hamilton General Hospital (CA)
- Heidelberg University (DE)
- University of Michigan (US)
- University of California, San Francisco (US)
- McGill University Health Centre (CA)
- Corresponding author
- Korshunov, A.
- Taylor, M. D.
- ORCID
- Mack, S. C.
- Witt, H.
- Piro, R. M.
- Gu, L.
- Stütz, A. M.
- Wang, X.
- Gallo, M.
- Garzia, L.
- Zhang, X.
- Ramaswamy, V.
- Jäger, N.
- Jones, D. T. W.
- Sill, M.
- Pugh, T. J.
- Ryzhova, M.
- Wani, K. M.
- Shih, D. J. H.
- Remke, M.
- Bailey, S. D.
- Zichner, T.
- Faria, C. C.
- Barszczyk, M.
- Hutter, S.
- Johann, P.
- Hovestadt, V.
- Tzaridis, T.
- Dubuc, A. M.
- Northcott, P. A.
- Bertrand, K. C.
- Agnihotri, S.
- Cavalli, F. M. G.
- Creasy, C. L.
- Verma, S. K.
- Wu, X.
- Yao, Y.
- Milde, T.
- Zuccaro, J.
- Lau, L.
- Pereira, S.
- Hirst, M.
- Marra, M. A.
- Roberts, S. S.
- Fults, D.
- Massimi, L.
- Cho, Y. J.
- Grajkowska, W.
- Lach, B.
- Kulozik, A. E.
- Witt, O.
- Scherer, S. W.
- Fan, X.
- Muraszko, K. M.
- Kool, M.
- Pomeroy, S. L.
- Gupta, N.
- Phillips, J.
- Huang, A.
- Tabori, U.
- Hawkins, C.
- Malkin, D.
- Kongkham, P. N.
- Weiss, W. A.
- Jabado, N.
- Rutka, J. T.
- Korbel, J. O.
- Lupien, M.
- Aldape, K. D.
- Bader, G. D.
- Eils, R.
- Lichter, P.
- Dirks, P. B.
- Pfister, S. M.
- Korshunov, A.
- Taylor, M. D.
- Venue
- Nature
- Published
- 2014-02
- Volume
- 506
- Issue
- 7489
- Pages
- 445-450
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4174313
- OpenAlex
- W2113432767
- Cited by
- 607
- References
- 50
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 30 · 2023: 29 · 2022: 37 · 2021: 51 · 2020: 56 · 2019: 55 · 2018: 68 · 2017: 64 · 2016: 73 · 2015: 57 · 2014: 40
- FWCI
- 39.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Pediatric Brain Tumor Foundation
- CureSearch for Children's Cancer
- Deutsches Krebsforschungszentrum
- Government of Ontario
- Bundesministerium für Bildung und Forschung (01KU1201A, 01GS0883)
- Terry Fox Research Institute
- Deutsche Krebshilfe (109252)
- Deutschen Konsortium für Translationale Krebsforschung
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01CA148699, R01CA148621, R01CA121941, R01CA163737, R01CA159859, P30CA016672, P50CA097257)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- ependymoma, CpG island methylator phenotype, pediatric brain tumors, C11orf95-RELA fusion, chromothripsis, NF-κB signaling, H3K27me3, polycomb repressive complex 2, DNA methylation, EZH2 inhibitors, epigenetic therapy, tumor suppressor
- MeSH terms
- Animals, Brain Neoplasms, Ependymoma, Female, Histones, Humans, Infant, Mutation, Phenotype, Prognosis, Rhombencephalon, Gene Expression Regulation, Neoplastic, Mice, SCID, Mice, Inbred NOD, CpG Islands, DNA Methylation, Gene Silencing, Xenograft Model Antitumor Assays, Epigenesis, Genetic, Mice, Embryonic Stem Cells, Epigenomics, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
